🇺🇸 FDA
Pipeline program

Aramchol

Aramchol005

Phase 2 small_molecule completed

Quick answer

Aramchol for Fatty Liver is a Phase 2 program (small_molecule) at Galmed Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Galmed Pharmaceuticals
Indication
Fatty Liver
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials